Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
This research study is being done to learn if the study drug belantamab mafodotin, in
combination with other standard medications, can improve multiple myeloma. This study will
also help determine what effects, good and/or bad, this combination of study drugs have on
subjects and their cancer, and to evaluate the overall response to this study treatment
combination.